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ABSTRACT: 
Context: The European white-berry mistletoe [Viscum album L. (Loranthaceae)] is among the 
oldest known medicinal plants. At present the most important application of mistletoe 
extracts is treatment of cancer. However, natural products specific to mistletoe have rarely 
been encountered in current literature.  
Objective: To discover novel natural products specific to European mistletoe. 
Materials and methods: European mistletoe was extracted with methanol, purified to partition 
against diethyl ether and further purified with XAD-7 column chromatography. Pure 
compounds were separated by Sephadex column chromatography and preparative HPLC. The 
structures of the novel compounds were established using a combination of several 2D NMR 
spectroscopic techniques and mass spectrometry.   
Results: A new type of natural product derived from the methyl ester of 
gammahydroxybutyric acid (GHB) coupled to hydroxybenzoic acids, namely 3-(3′-
carbomethoxypropyl) gallic acid and 3-(3′-carbomethoxypropyl)-7→3′′-protocatechoyl 
galloate were characterized from European white-berry mistletoe. Condensation of the 3-
hydroxyl of gallic acid with the 4-hydroxyl of GHB significantly reduced the radical 
scavenging properties of the former compound. 
Discussion and conclusion: The compounds characterized define a novel group of natural 
products that may be of particular interest because it appears that the two new compounds are 







For thousands of years, secondary metabolites from plants have continued to play an 
important role in medicine (Ji et al. 2009). Recently, Newman (2008) estimated that 
approximately 60% of the drugs available are either directly or indirectly derived from natural 
products. In line with this, there is currently an increased interest in the study of traditional 
medicinal plants as sources of new drug candidates (Muthu et al. 2006). European white-berry 
mistletoe [Viscum album L. (Loranthaceae)], order Santalales (APG3, 2009) is an evergreen 
dioecious small shrub growing half parasitically on a tree host in temperate Europe and 
western Asia. European mistletoe has been utilized as an important medicinal plant for 
millennia. Conditions treated with European mistletoe include hypertension, diabetes, 
arthrosis, epilepsy and cancer (Büssing, 2000 and references therein). In particular, the 
anticancer activity of mistletoe extracts has been extensively studied. The anticancer activity 
of mistletoe extracts has been ascribed to the presence of lectins (Franz 1986), viscotoxins 
(Romagnoli et al. 2000) and alkaloids (Khwaja et al. 1980 and 1986; Park et al. 1998, 1999; 
Chen et al. 2005 and references therein; Dong et al. 2009; Ge et al. 2009; Zhou et al. 2010). 
Although European mistletoe has remained an important medicinal plant for millennia, 
limited information is available about the content of secondary metabolites. The chemical 
composition of European mistletoe extracts is rather complex (Bar-Sela 2011 and references 
therein) and only a very limited number of natural products have been identified therefrom. 
Recently we identified two novel aminoalkaloids from European mistletoe, which were the 
first alkaloids ever to be identified from this species (Amer et al. 2012). The major objective 
of the current study was to isolate novel compounds from European mistletoe which may 
have potential as future drug candidates. In this paper we report on the isolation and 
characterisation of a novel group of natural products derived from gammahydroxybutyric acid 
(GHB) coupled to phenolic acids isolated from Viscum album. 
Materials and methods 
Extraction of plant material  
Plant material and host tree V. album [source: Lille, France, host tree: a hybrid of Populus 
nigra L. with P. deltoids Bartram ex Marshall = P. x canadensis Moench (Salicaceae)] was 
identified by Professor Frederic Dupont, Department of Botany, Faculty of Pharmacy, 
University of Lille 2. The European mistletoe used in this work grows in the botanical garden 
of Department of Botany, Faculty of Pharmacy, University of Lille 2. A voucher specimen 
has been deposited (accession number LIP-BOTA-12070201). Fresh plant material of Viscum 
album (1.5 kg) was chopped using a blender and extracted three times with methanol (6 L) at 
room temperature for 24 h. The extracts were stored in a refrigerator at 4◦C. The crude extract 
was filtered through a glass wool filter. Water in the plant was approximately 60%, since 10 g 
of the fresh plant material lost 6 g after drying in oven at 110◦C for 30 h. The methanol extract 
was concentrated under reduced pressure on a rotavapor and purified by partition against 
diethyl ether to remove non-polar aliphatic compounds. A dark brown solution was left after 
removal of the latter. 
 
Instruments and equipment  
Concentration under reduced pressure was performed with a Büchi Rotavapor, R-205. 
Adsorption column chromatography was performed with a 105 x 5 cm Amberlite XAD-7 
column (Amberlite XAD-7HP, Particle size: 20-60 mesh, wet, Sigma Aldrich). Gel filtration 
chromatography was performed on a Sephadex LH-20 column (100 x 5 cm). Analytical 
HPLC was performed with an Agilent 1100 HPLC equipped with a HP 1050 mutidiode array 
detector, a 20 µl loop and a 250 x 4.6 mm, 5 µm Hypersil GOLD column. Preparative HPLC 
was performed with a Gilson 321 HPLC with UV detection (Dionex UltiMate 3000 Variable 
Wavelength Detector). The system was equipped with a 250 x 22 mm, C18 Altech column. 
High resolution mass spectra were recorded using a JEOL AccuTOF JMS T100LC instrument 
fitted with a DART inlet from Ion Sense. The NMR experiments were performed on a Bruker 
600 MHz instrument equipped with a cryogenic probe. 
 
Amberlite XAD-7 column chromatography 
The concentrated purified aqueous extract was applied to an Amberlite XAD-7 column. The 
column was eluted with distilled water (5 L) to remove polar aliphatic constituents. The 
purified extract was eluted with methanol (5 L). Elution with methanol (5 L) furnished a 
purified fraction that was concentrated under reduced pressure using a rotavapor. 
 
Sephadex LH-20 column chromatography 
The concentrated XAD-purified extract was applied to a Sephadex LH-20 column. The 
column was eluted with a solvent gradient. Fractions 1-18 were eluted using 3.6 L of 
methanol-distilled water-TFA (60:40:0.2; v/v) as mobile phase while fractions 19-43 were 
obtained using 2 L of methanol-distilled water-TFA (70:30:0.2; v/v) as mobile phase. 
Fractions 44-48 were eluted using 1 L of methanol-distilled water-TFA (75:25:0.2; v/v) as 
mobile phase. The last fractions (49-58) were eluted using 1 L of methanol-distilled water-
TFA (80:20:0.2; v/v) as mobile phase. The eluted fractions were concentrated under reduced 
pressure using a rotavapor and checked for purity by analytical HPLC. Pure compound 1 (400 
mg) was obtained from fraction 29. Fraction 35 contained 25 mg pure compound 2. 
Compound 3 was isolated from fraction 47 on preparative HPLC as described below. 
 
Analytical HPLC 
Two solvents; A, distilled water and 0.5 % TFA (trifluoroacetic acid) and B, acetonitrile and 
0.5 % TFA (trifluoroacetic acid) were used for elution. The elution profile consisted of 90% A 
and 10% B, followed by gradient elution for 10 min (14% B), isocratic elution for 10–14 min, 
and the subsequent gradient conditions: 18 min (16% B), 22 min (18% B), 26 min (23% B), 
31 min (28% B), and 32 min (40% B), isocratic elution for 32–40 min, gradient elution for 
40–43 min (10% B) and final linear elution for 43–46 min (10% B). The flow rate was 1.0 
ml/min, and aliquots of 15 μl were injected with a Micro Auto-sampler (Agilent 1100 Series).  
 
Preparative HPLC 
Two solvents; A, distilled water and 1.0% TFA (trifluoroacetic acid) and B, methanol and 
1.0% TFA (trifluoroacetic acid) were used for elution. The elution profile consisted of 90% A 
and 10% B for 0-4 min, followed by gradient elution for 4-40 min (10–90% B), isocratic 
elution for 44-57 min and final linear elution for 57-58 min (90–10% B). The flow rate was 
15.0 ml/min, and aliquots of 1000 μl were injected with a microliter syringe. Following this 
procedure compound 3 (2 mg) was eluted after 29.8 min.  
 
Spectroscopy 
i) UV spectroscopy 
UV-Vis absorption spectra were recorded on-line during HPLC analysis over the wavelength 
range 240-600 nm in steps of 2 nm. 
ii) Mass spectrometry 
The isolated compounds were dissolved in methanol. A glass needle was soaked in the analyte 
solution, and thereafter placed in the source at atmospheric pressure. The analysis was 
performed at a helium flow rate 0.76 L/min, gas temperature 300◦C and a needle voltage of 
approximately 3000 V. Mass spectral data were recorded at orifice 1 voltage 19 V, orifice 2 
voltage 7 V, ring lens voltage 8 V and detector voltage 2300 V. The spectrum was recorded 
over the mass range 50-1000 m/z. 
 iii) NMR spectroscopy 
NMR samples were prepared by dissolving the isolated compounds in deuterated 
dimethylsulphoxide (99.9 atom % D, Sigma-Aldrich). The 1D 1H, the 1D 13C CAPT and the 
2D 1H-13C HMBC, 1H-13C HSQC, 1H-1H COSY and 1H-1H ROESY NMR experiments were 
obtained at 600.13 MHz and 150.90 MHz for 1H and 13C, respectively, at 298K.  
 
DPPH scavenging activity 
These experiments were performed in accordance with the procedure described by Glavind 
(1963) and Lyckander and Malterud (1996), with some modifications outlined below. 
Methanol solutions of 1,1-diphenyl-2-picrylhydrazyl radical (DPPH) (190 μl, 45 μg/ 
ml) were mixed with the test substances 3-(3′-carbomethoxypropyl)gallic acid and gallic acid 
(10 μl) in 96 well UV-transparent microtiter plates (Greiner; cyclic olefin copolymer (COC) 
flat bottom). The decrease in absorption at 517 nm was measured over a period of 30 min 
using an EON Biotek absorbance microplate reader. All experiments were performed at 25◦C. 
 
Results 
Fresh plant material of Viscum album L. was extracted with methanol. After removal of 
methanol under reduced pressure, the concentrated extract was purified by partition against 
diethyl ether. The aqueous phase was purified with XAD-7 Amberlite adsorption 
chromatography. Pure compounds, 1 (400 mg) and 2 (25 mg), were isolated by Sephadex LH-
20 chromatography. Compound 3 (2 mg) was isolated from a Sephadex fraction on 
preparative HPLC. 
The absorption maxima of the UV-Vis spectra of 1-3 at ~ 250-260 nm were compatible with 
aromatic compounds based on substituted hydroxybenzoic acid core structures. 
Compound 1 was identified as gallic acid (3,4,5-trihydroxybenzoic acid) by 1D and 2D NMR 
spectroscopy (Table 1 and figure 2). A quasi-molecular ion [MH]+ at m/z 171.029  in the high 
resolution mass spectrum of 1 corresponding to C7H5O5 (calc. 171.029) confirmed this 
identity. From 1.5 kg fresh plant material 400 mg of the pure substance was isolated. The 
water content of the fresh plant material was determined to be 60 % of the total weight. Thus, 
gallic acid comprises approximately 0.07 % of the dry weight of European mistletoe. The 
substance has previously been identified in Viscum album by Popova (1991) along with 
chlorogenic, caffeic and ferulic acids.  
The aromatic region of the 1D 1H NMR spectrum of 2 showed a 2H AB system at δ 7.14 (d 
2.0 Hz, H-6) and δ 7.06 (d 2.0 Hz, H-2) and 1H singlets at δ 9.51 (5-OH) and δ 8.76 (4-OH), 
which is in accordance with an asymmetrically monosubstituted derivative of gallic acid. The 
aliphatic region of the 1D 1H NMR spectrum showed a singlet at δ 3.55 (OCH3), in addition 
to three connected -CH2- groups at δ 2.37 (t 7.4 Hz, H-2′), δ 1.69 (p 7.4 Hz, H-3′) and δ 3.44 
(t 7.4 Hz, H-4′), all of which agree with identification of the compound as the methyl ester of 
gammahydroxybutyric acid. The identification of gallic acid and the methyl ester of 
gammahydroxybutyric acid as sub-units of 2 was confirmed by the observations of the twelve 
13C signals in the 1D 13C CAPT spectrum (Table 1). The individual 1H signals of the methyl 
ester of gammahydroxybutyric acid subunit were assigned by the 2D 1H-1H COSY 
experiment (Table 1). A crosspeak at δ 3.44/136.5 (H-4′/C-3) observed in the 2D 1H-13C 
HMBC spectrum confirmed the identity of 2 to be the novel natural product 3-(3′-
carbomethoxypropyl) gallic acid (figure 2). A quasimolecular ion [MH+] corresponding to 
C12H15O7 confirmed this identity. The NMR spectra of 3 shared many similarities to that of 2 
showing the presence of a unit of gallic acid substituted with a 3′-carbomethoxypropyl unit at 
the 3-hydroxyl (Table 1). In addition, the carboxyl group of the galloyl subunit was esterified 
with a hydroxyl of 3,4-dihydroxybenzoic acid, which showed a 1H singlet at  δ 9.86 (4′′-OH) 
and a 3H ABX system at δ 7.48 (dd 2.1, 8.3 Hz, H-6′), δ 7.44 (d 2.1 Hz, H-2′′) and δ 6.82 (d 
8.3 Hz, H-5′′) in the aromatic region of the 1D 1H NMR spectrum of 3, which is in accord 
with a mono O-substituted unit of protocatechuic acid (Table 1). The identification was 
supported by the observation of 19 individual 13C resonances in the 1D 13C CAPT spectrum of 
3. All 13C signals were assigned by the 2D 1H-13C HSQC and HMBC spectra. The individual 
1H signals of the methyl ester of gammahydroxybutyric acid subunit were assigned by the 2D 
1H-1H COSY experiment (Table 1). The strong crosspeak at δ 9.86/6.82 (4′′-OH/H-5′′) 
observed in the 2D 1H ROESY spectrum of 3 showed that the only remaining phenolic OH 
group of the substituted protocatechuic acid subunit was positioned at the 4′′-position. Based 
thereupon, the position of esterification between the carbonyl carbon of the galloyl subunit 
and protocatechuic acid subunit was determined to be at the 3′′-position (figure 2). Moreover, 
a crosspeak at δ 3.44/136.1 (H-4′/C-3) observed in the 2D 1H-13C HMBC spectrum confirmed 
the linkage between the 3′-carbomethoxypropyl unit and the galloyl moiety to be at the 3-
hydroxyl. Thus, the structure of 3 was established as the novel natural product 3-(3′-
carbomethoxypropyl)-7→3′′-protocatechoyl galloate. A molecular ion m/z 406.092 
corresponding to C19H18O10, (calc. 406.089) and ions due to simple losses from this of CO2 at 
m/z 362.100 (calc. 362.099) and CH2CH2CO2Me at m/z 319.057 (calc. 319.045) were in 
accord with this identity. Fragment ions due to rearrangement scission of the ester bond 
corresponding in mass to the loss of orthoquinone-4-carboxylic acid at m/z 254.078 (calc. 
254.078), and of methanol from the latter at m/z 222.051 (calc. 222.052), together with 
observation of a fragment corresponding to orthoquinone-4-carboxylate at m/z 151.055 (calc. 
151.003) in the mass spectrum of 3 lent further support to this identification (Figure 3). 
The radical scavenging properties of compounds 1 and 2 were determined with the DPPH 
(Diphenylpicrylhydrazyl) assay (Glavind 1963; Lyckander & Malterud, 1996). Gallic acid has 
previously been reported to be a potent radical scavenger (Masaki et al. 1994) and the 
calculated IC50 for this compound was 27.7 μM. Substitution of the 3-hydroxyl of gallic acid 
with methyl ester of GHB, which is the case for compound 2, reduced the radical scavenging 
properties twenty-fold compared with that of gallic acid (IC50 for compound 2 = 222 μM; 
Table 2). 
Discussion 
Since the 1920s extracts of European mistletoe (Viscum album) have been used in the 
treatment of cancer (Lev et al. 2011 and references therein). The anticancer activity of these 
extracts has previously been ascribed to three main groups of compounds, namely (1) lectins, 
a group of proteins with relatively high molecular weight which become denatured and loose 
their activity upon heating, apparently due to disruption of their tertiary structure (Franz 
1986), (2) viscotoxins, a group of more heat-stable proteins with considerably lower 
molecular weights (Romagnoli et al. 2000), and (3) alkaloids, which we identified very 
recently (Amer et al. 2012).  
In this paper we report on the identification in European mistletoe of two novel compounds 
consisting of phenolic acids merged with the methyl ester of gammahydroxybutyric acid. In 
addition, a substantial amount of gallic acid, which is one of the main building blocks of these 
compounds, was isolated from the same source. Gallic acid, and some derivatives thereof 
have previously been reported to exhibit promising anticancer activity against different cancer 
cell lines including prostate cancer, mammary gland and cervix adenocarcinomas and 
lymphoblastic leukemia cancer cell lines (Gomes et al. 2003; Indap et al. 2006; Agarwal et al. 
2006; Saxena et al. 2008; Kaur et al. 2009). Gammahydroxybutyric acid has previously been 
reported to exhibit anti-angiogenic activities and antitumor effect in animal trials (Basaki et 
al. 2002). Future analysis to reveal the therapeutic potential of the compounds reported in this 




The discovery of several novel natural products from European mistletoe justifies further 
investigations into this traditional medicinal plant. European mistletoe has been used for 
treatment of cancer with success although the chemical composition of preparations from this 
plant have been poorly characterised. This is particularly valid with respect to medium-sized 
organic molecules belonging to the main molecular regime relevant in the search for new drug 
candidates (Chin et al. 2006). The methods used in the current paper open possibilities for 
isolation of new compounds from this source that has previously been regarded as having an 
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Figure 1. European white-berry mistletoe (Viscum album) photographed in Hamburg 
11.11.2005. Photo: Professor Frédéric Dupont. 
 
Figure 2. Structures of compounds 1-3 isolated from European mistletoe (Viscum album) 
 
Figure 3. Mechanisms for formation of important fragments observed in the mass spectrum 
of compound 3 
Table 1. 1H and 13C NMR chemical shift values (ppm) and coupling constants (Hz) of 
compounds 1-3 isolated from European mistletoe (Viscum album). 
 
 
Compound 3 3 2 2 1 1 
 δ 1H δ 13C δ 1H δ 13C δ 1H δ 13C 
Galloyl       
1  120.65  120.7  120.50 
2 7.07 d 2.0 116.80 7.06 d 2.0 116.6 6.90 s 108.79 
3  136.09  136.5  145.49 
3-OH     9.16 s  
4  144.56  144.5  138.06 
4-OH 8.76 s  8.76 s  8.80 s  
5  145.30  145.4  145.49 
5-OH 9.55 s  9.51 s  9.16 s  
6 7.14 d 2.0 112.06 7.14 d 2.0 112.1 6.90 s 108.79 
7  167.40  167.3  167.54 
3-GHB-
OMe 
      
1’  173.32  173.3   
2’ 2.38 t 7.4  30.75 2.37 t 7.4 30.8   
3’ 1.70 p 7.4  22.96 1.69 p 7.4 23.1   
4’ 3.44 t 7.4  50.79 3.44 t 7.4 51.2   
OMe 3.55 s 51.31 3.55 s 51.3   
7→3’’-PCA       
1’’  121.70     
2’’ 7.44 d 2.1 124.71     
3’’  136.44     
4’’  155.71     
4’’-OH 9.86 s      
5’’ 6.82 d 8.3 115.76     
6’’ 7.48 dd 2.1, 
8.3 
125.82     


























Series 1     
%  DPPH 
scavenged 











Gallic acid : DPPH 
Molar ratio  
(both series) 
2.1 3.3 12.0 7.7 6.2 0.004 
4.1 5.8 8.2 7.0 1.7 0.007 
6.2 13.6 20.1 16.9 4.7 0.011 
8.2 19.8 19.2 19.5 0.5 0.015 
10.3 19.2 21.3 20.2 1.4 0.019 
20.6 42.5 46.0 44.2 2.5 0.037 
41.1 79.1 86.1 82.6 5.0 0.074 
61.7 94.5 93.9 94.2 0.4 0.112 
Table 3. DPPH scavenging activity of 3-(3’-carbomethoxypropyl) gallic acid(2). Values 




[2] μM  Series 1              % DPPH scavenged 










Gallic acid : 
DPPH 
Molar ratio  
(both series) 
63.5 21.1 20.5 20.8 0.4 0.278 
105.8 30.7 30.6 30.7 0.1 0.464 
169.3 42.8 42.6 42.7 0.1 0.742 
211.6 48.8 47.1 47.9 1.2 0.927 
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